Mutations disrupting the kinase domain of IKKα lead to immunodeficiency and immune dysregulation in humans
Journal of Experimental Medicine · 2025
DOI: 10.1084/jem.20240843 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Experimental Medicine, 2025. Verfasst von Quentin Riller und 34 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, Imagine Institute, University Paris Cité, Paris, France. Hauptthemen laut MEDLINE: I-kappa B Kinase, NF-kappa B, Immunologic Deficiency Syndromes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Advancing Science and Practice in the Retail Environment, Fonds National de la Recherche Scientifique, Grandir-Fonds de solidarité pour l'enfance.
Abstract (Originalsprache)
IKKα, encoded by CHUK, is crucial in the non-canonical NF-κB pathway and part of the IKK complex activating the canonical pathway alongside IKKβ. The absence of IKKα causes fetal encasement syndrome in humans, fatal in utero, while an impaired IKKα-NIK interaction was reported in a single patient and causes combined immunodeficiency. Here, we describe compound heterozygous variants in the kinase domain of IKKα in a female patient with hypogammaglobulinemia, recurrent lung infections, and Hay–Wells syndrome-like features. We showed that both variants were loss-of-function. Non-canonical NF-κB activation was profoundly diminished in stromal and immune cells while the canonical pathway was unexpectedly partially impaired. Reintroducing wt CHUK restored non-canonical NF-κB activation. The patient had neutralizing autoantibodies against type I IFN, akin to non-canonical NF-κB pathway deficiencies. Thus, this is the first case of biallelic CHUK mutations disrupting IKKα kinase function, broadening non-canonical NF-κB defect understanding, and suggesting IKKα’s role in canonical NF-κB target gene expression in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, Imagine Institute, University Paris Cité, Paris, France.
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM UMR 1163, Imagine Institute, University Paris Cité, Paris, France.
- Clinical Immunology Department, Assistance Publique Hôpitaux de Paris (AP-HP), Saint-Louis Hospital, Paris, France.
- Laboratory of Molecular Immunology and Signal Transduction, GIGA-Institute, University of Liège, Liège, Belgium.
- NF-κB, Differentiation and Cancer, URP7324, University Paris Cité, Paris, France.
- Pediatric Radiology Department, AP-HP, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
ORCID-Profile: Quentin Riller, Boris Sorin, Charline Courteille, Duong Ho-Nhat, Tom Le Voyer, Jean-Christophe Debray, Marie-Claude Stolzenberg, Muriel Schmutz, Olivier Pellé, Thomas Becquard, María Rodrigo Riestra, Laureline Berteloot, Mélanie Migaud, Laure Delage, Marie Jeanpierre, Charlotte Boussard, Camille Brunaud, Aude Magérus, Charles Bretot, Victor Michel, Camille Roux, Capucine Picard, Cécile Masson, Christine Bole-Feysot, Nicolas Cagnard, Aurélien Corneau, Isabelle Meyts, Véronique Baud, Jean-Laurent Casanova, Alain Fischer, Emmanuel Dejardin, Anne Puel, Cécile Boulanger, Bénédicte Neven, Frédéric Rieux-Laucat
Förderung
- Advancing Science and Practice in the Retail Environment
- Fonds National de la Recherche Scientifique
- Grandir-Fonds de solidarité pour l'enfance
- Battersea & Bowery Advisory Group
- Institut National de la Santé et de la Recherche Médicale
- Fonds Wetenschappelijk Onderzoek
- St Giles Foundation
- NIAID NIH HHS
Zitieren
APA
Riller, Q., Sorin, B., Courteille, C., Ho-Nhat, D., Le Voyer, T., Debray, J. C., Stolzenberg, M. C., Schmutz, M., Pellé, O., Becquard, T., Rodrigo Riestra, M., Berteloot, L., Migaud, M., Delage, L., Jeanpierre, M., Boussard, C., Brunaud, C., Magérus, A., Bretot, C., …, & Rieux-Laucat, F. (2025). Mutations disrupting the kinase domain of IKKα lead to immunodeficiency and immune dysregulation in humans. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20240843
Vancouver
Riller Q, Sorin B, Courteille C, Ho-Nhat D, Le Voyer T, Debray JC, et al. Mutations disrupting the kinase domain of IKKα lead to immunodeficiency and immune dysregulation in humans. Journal of Experimental Medicine. 2025. doi:10.1084/jem.20240843
BibTeX
@article{Riller2025,
author = {Riller, Quentin and Sorin, Boris and Courteille, Charline and Ho-Nhat, Duong and Le Voyer, Tom and Debray, Jean-Christophe and Stolzenberg, Marie-Claude and Schmutz, Muriel and Pellé, Olivier and Becquard, Thomas and Rodrigo Riestra, María and Berteloot, Laureline and Migaud, Mélanie and Delage, Laure and Jeanpierre, Marie and Boussard, Charlotte and Brunaud, Camille and Magérus, Aude and Bretot, Charles and Michel, Victor and Roux, Camille and Picard, Capucine and Masson, Cécile and Bole-Feysot, Christine and Cagnard, Nicolas and Corneau, Aurélien and Meyts, Isabelle and Baud, Véronique and Casanova, Jean-Laurent and Fischer, Alain and Dejardin, Emmanuel and Puel, Anne and Boulanger, Cécile and Neven, Bénédicte and Rieux-Laucat, Frédéric},
title = {Mutations disrupting the kinase domain of IKKα lead to immunodeficiency and immune dysregulation in humans},
journal = {Journal of Experimental Medicine},
year = {2025},
doi = {10.1084/jem.20240843}
}
EUVIMED